Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
Life on hold: the experience of living with neuromyelitis optica.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Functional Cognitive Disorder: A Common Cause of Subjective Cognitive Symptoms.
Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.
Incidence of Radiologically Isolated Syndrome: A Population-Based Study.
Simultaneous Development of Acute Disseminated Encephalomyelitis and Guillain-Barré Syndrome Associated with H1N1 09 Influenza Vaccination.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.
Multiple sclerosis and restless legs syndrome: a systematic review and meta-analysis.
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging.
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran.
Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
Pages
« first
‹ previous
…
367
368
369
370
371
372
373
374
375
…
next ›
last »